66 results
S-8
EX-4.2
VKTX
Viking Therapeutics Inc
22 May 24
Registration of securities for employees
4:33pm
, of the Participant’s personal data as described
herein and any other applicable Award grant materials by and among, as applicable, the Company or any of its Affiliates … with manufacturers or suppliers of active pharmaceutical ingredients and other component materials and manufacturers of the Company’s products); co
DEFA14A
VKTX
Viking Therapeutics Inc
5 Apr 24
Additional proxy soliciting materials
4:10pm
Definitive Additional Materials
☐ Soliciting Material Pursuant to §240.14a-12
VIKING THERAPEUTICS, INC.
(Name of Registrant as Specified In Its Charter … paid previously with preliminary materials
☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
424B5
VKTX
Viking Therapeutics Inc
1 Mar 24
Prospectus supplement for primary offering
4:13pm
, and will not be offered or sold, directly or indirectly in New Zealand and no offering materials or advertisements have been or will be distributed
424B5
hs405xkqq164oq35x
27 Feb 24
Prospectus supplement for primary offering
5:21pm
8-K
EX-3.1
f9m11y89i0 8wei
11 May 23
Amendments to Articles of Incorporation or Bylaws
5:00pm
DEFA14A
7exu1f
1 May 23
Additional proxy soliciting materials
4:21pm
PRE 14A
g457b 9v42
17 Apr 23
Preliminary proxy
5:04pm
8-K
EX-1.1
tux6umewp5b
31 Mar 23
Viking Therapeutics Announces Pricing of $250 Million Public Offering of Common Stock
5:27pm
424B5
sxb3 kj63oakcvi
31 Mar 23
Prospectus supplement for primary offering
5:24pm
424B5
neo0t
29 Mar 23
Prospectus supplement for primary offering
4:01pm